Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-06

Clinical Trial Update: Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results for LIK066 assessing its effect on glucose absorption in adults with type 2 diabetes mellitus, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIK066 (LIK066)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-02-06